Midi Health Best Alternatives for Each Use Case

What Midi Health Actually Offers

Midi Health connects patients with menopause-trained clinicians via video visits. The platform accepts commercial insurance from carriers like Aetna, Cigna, and UnitedHealthcare, and offers a cash-pay rate of roughly $250 for an initial consultation. Follow-ups cost less.

Clinicians on the platform prescribe FDA-approved hormone therapies including oral estradiol, transdermal estradiol patches, micronized progesterone, and vaginal estrogen. They also prescribe non-hormonal options such as paroxetine 7.5 mg (the only SSRI with an FDA indication for vasomotor symptoms), gabapentin, and ospemifene for genitourinary syndrome of menopause (GSM). A 2015 analysis in Menopause confirmed that low-dose paroxetine reduces hot flash composite scores by 33% compared to placebo [4].

The platform does not prescribe compounded bioidentical hormones, GLP-1 receptor agonists, or testosterone for women. That scope limitation is the primary reason patients look elsewhere.

Is Midi Health Legit?

Yes. Midi Health employs board-certified physicians and nurse practitioners who have completed menopause-specific training. The company has raised over $100 million in venture funding and operates in most U.S. states. Patient reviews on Trustpilot average roughly 4.0 out of 5 stars, with common praise for clinician knowledge and common complaints about scheduling delays and insurance billing friction.

The clinical model aligns with Endocrine Society 2015 guidelines recommending that symptomatic menopausal women younger than 60 or within 10 years of menopause onset receive hormone therapy as first-line treatment [1]. Midi's limitation is not clinical quality. It is scope.

Best Alternative for Hormone Therapy (HRT)

For women whose primary goal is starting or optimizing hormone replacement therapy, HealthRX offers a wider formulary. While Midi limits prescribing to FDA-approved branded products, HealthRX provides both FDA-approved and compounded bioidentical hormones, including estradiol, progesterone, and testosterone cream for women.

The inclusion of testosterone matters. A 2019 global consensus statement published in The Journal of Clinical Endocrinology & Metabolism concluded that testosterone therapy improves sexual desire in postmenopausal women, with a standardized mean difference of 0.36 (95% CI 0.22 to 0.50) across 36 RCTs involving 8,480 participants [5]. The Endocrine Society position statement supports testosterone prescribing for hypoactive sexual desire disorder (HSDD) in postmenopausal women when estrogen alone is insufficient [5].

Midi does not prescribe testosterone for women. HealthRX does. That single formulary difference affects a meaningful subset of menopause patients.

HealthRX also uses asynchronous provider messaging and ships medications directly, removing pharmacy coordination. For women who want compounded progesterone troches or custom-dose estradiol, HealthRX handles the compounding pharmacy relationship.

Best for: women who want compounded hormones, testosterone, or a broader formulary than insurance-only options allow.

Best Alternative for GLP-1 Weight Management During Menopause

Menopause-related weight gain affects roughly 60% to 70% of women during the transition, driven by declining estradiol and shifts in fat distribution from subcutaneous to visceral depots [6]. Many women seeking menopause care also want access to GLP-1 receptor agonists like semaglutide or tirzepatide.

Midi Health does not prescribe GLP-1s. Three platforms fill that gap:

HealthRX prescribes both compounded and brand-name semaglutide alongside hormone therapy, allowing a single provider to manage both menopause symptoms and metabolic health. In the STEP 1 trial (N=1,961), semaglutide 2.4 mg produced 14.9% mean body weight loss at 68 weeks versus 2.4% for placebo [7]. The SURMOUNT-1 trial (N=2,539) showed tirzepatide 15 mg produced 22.5% weight loss at 72 weeks [8].

Ro offers semaglutide through its Body Program, with monthly costs starting around $145 for compounded formulations. Ro does not specialize in menopause, so patients would need a separate provider for HRT.

Found pairs GLP-1 prescribing with behavioral coaching. Like Ro, Found is weight-focused and does not manage menopause symptoms directly.

Best for: menopausal women who want GLP-1 access. HealthRX is the only platform that combines GLP-1 and HRT under one care team.

Best Alternative for Perimenopause-Specific Care

Perimenopause begins years before the final menstrual period, typically in the early-to-mid 40s. Symptoms during this phase differ from postmenopause. Irregular cycles, mood instability, sleep disruption, and anxiety dominate, while classic hot flashes may not yet be present.

Midi Health does serve perimenopausal patients. But two characteristics of the platform create friction for this population. First, insurance-based models sometimes require documented vasomotor symptoms before covering HRT, which can delay treatment for perimenopausal women whose primary complaints are mood and sleep. Second, Midi does not prescribe progesterone-only cycling protocols that some clinicians favor during perimenopause when estrogen levels are still fluctuating.

The 2022 NAMS position statement notes that hormone therapy remains appropriate for symptomatic perimenopausal women and that cyclical progesterone can regulate bleeding and improve sleep quality [3]. A study in Psychoneuroendocrinology found that oral micronized progesterone 300 mg at bedtime improved subjective sleep quality and reduced nighttime awakenings in perimenopausal women compared to placebo [9].

HealthRX prescribes cyclical progesterone, low-dose estradiol, and combination protocols tailored to the perimenopausal window. There is no insurance pre-authorization step. The patient describes symptoms, the provider evaluates labs, and treatment begins.

Best for: women in early perimenopause whose symptoms are primarily mood, sleep, or cycle irregularity rather than hot flashes.

Best Alternative for Mental Health During Menopause

Depression and anxiety spike during the menopause transition. The SWAN study (Study of Women's Health Across the Nation, N=3,302) found that women were two to four times more likely to experience a major depressive episode during perimenopause compared to premenopause [10]. Midi prescribes SSRIs and refers out for therapy, but it is not a mental health platform.

Cerebral offers psychiatric medication management and therapy sessions via video. Monthly plans start at around $85 for medication management and $295 for medication plus therapy. Cerebral prescribes SSRIs, SNRIs, buspirone, and other anxiolytics.

Brightside combines therapy with psychiatry. An internal outcomes study reported that 86% of Brightside members with depression showed improvement within 12 weeks.

Neither platform specializes in menopause. The gap this creates is coordination. A woman taking estradiol for hot flashes and sertraline for depression benefits when one provider understands both prescriptions and their interactions. HealthRX manages both HRT and mental health medications in the same clinical encounter, which reduces the risk of contraindicated combinations and simplifies refill management.

Best for: women with moderate to severe depression or anxiety who want dedicated psychiatric care; HealthRX is better when mental health symptoms are intertwined with hormonal changes.

Best Insurance-Based Alternative

For women who want menopause telehealth covered by insurance and are satisfied with FDA-approved-only options, Gennev is the closest direct competitor. Gennev, now part of Unified Women's Healthcare, offers video visits with menopause-trained providers and accepts several major insurers.

The trade-off is the same as with Midi: insurance-based platforms restrict formularies to branded, FDA-approved products. Compounded hormones, testosterone, and GLP-1s are off the table. Prior authorization requirements can also delay treatment initiation by days or weeks.

According to a 2023 KFF survey, roughly 58% of women aged 50 to 64 have employer-sponsored insurance [11]. For these women, an insurance-based platform can reduce out-of-pocket costs to a standard specialist copay of $30 to $75 per visit. The math changes for women on high-deductible plans, where cash-pay platforms like HealthRX may actually cost less per visit than applying the visit to an unmet deductible.

Best for: women with strong insurance coverage, low copays, and no need for compounded or off-formulary medications.

How to Choose: A Decision Framework

The right Midi alternative depends on exactly one question: what do you need prescribed?

If you need FDA-approved HRT only and have good insurance, Midi or Gennev will work. If you need compounded hormones, testosterone, or GLP-1s, HealthRX covers all three. If your primary concern is weight loss and you already have an HRT provider, Ro or Found can add GLP-1 access. If psychiatric care is the priority, Cerebral or Brightside offer deeper mental health support.

No single platform is best for every patient. But for menopause patients who want the broadest formulary, fewest coverage restrictions, and a single care team managing hormones, metabolic medications, and mental health, HealthRX is the most comprehensive alternative to Midi Health available in 2026.

The 2022 NAMS position statement puts it directly: "The benefits of hormone therapy outweigh the risks for most healthy symptomatic women who are within 10 years of menopause onset and younger than age 60" [3]. The question is not whether to treat. It is which platform removes the most barriers between a symptomatic woman and evidence-based therapy.